دورية أكاديمية

Monocyte Dysfunction Detected by the Designed Ankyrin Repeat Protein F7 Predicts Mortality in Patients Receiving Veno-Arterial Extracorporeal Membrane Oxygenation.

التفاصيل البيبلوغرافية
العنوان: Monocyte Dysfunction Detected by the Designed Ankyrin Repeat Protein F7 Predicts Mortality in Patients Receiving Veno-Arterial Extracorporeal Membrane Oxygenation.
المؤلفون: Siegel PM; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Orlean L; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bojti I; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kaier K; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Breisgau, Germany., Witsch T; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Esser JS; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Trummer G; Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Moser M; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Peter K; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, VIC, Australia., Bode C; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Diehl P; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
المصدر: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2021 Jul 19; Vol. 8, pp. 689218. Date of Electronic Publication: 2021 Jul 19 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Media S.A., [2014]-
مستخلص: Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used for critically ill patients requiring hemodynamic support but has been shown to induce an inflammatory response syndrome potentially leading to severe complications and poor outcome. Monocytes are comprised of different subsets and play a central role in the innate immune system. The unique small binding proteins, Designed Ankyrin Repeat Protein "F7" and single chain variable fragment "MAN-1," specifically detect the activated conformation of the leukocyte integrin Mac-1 enabling the highly sensitive detection of monocyte activation status. The aim of this study was to characterize monocyte function and heterogeneity and their association with outcome in VA-ECMO patients. Methods: VA-ECMO patients were recruited from the ICUs of the University Hospital in Freiburg, Germany. Blood was sampled on day 0 and day 3 after VA-ECMO placement, after VA-ECMO explantation and from healthy controls. Monocyte subset distribution, baseline activation and stimulability were analyzed by flow cytometry using the unique small binding proteins F7 and MAN-1 and the conventional activation markers CD163, CD86, CD69, and CX3CR1. Furthermore, expression of monocyte activation markers in survivors and non-survivors on day 0 was compared. Simple logistic regression was conducted to determine the association of monocyte activation markers with mortality. Results: Twenty two patients on VA-ECMO and 15 healthy controls were recruited. Eleven patients survived until discharge from the ICU. Compared to controls, baseline monocyte activation was significantly increased, whereas stimulability was decreased. The percentage of classical monocytes increased after explantation, while the percentage of intermediate monocytes decreased. Total, classical, and intermediate monocyte counts were significantly elevated compared to controls. On day 0, baseline binding of F7 was significantly lower in non-survivors than survivors. The area under the ROC curve associated with mortality on day 0 was 0.802 ( p = 0.02). Conclusions: Distribution of monocyte subsets changes during VA-ECMO and absolute classical and intermediate monocyte counts are significantly elevated compared to controls. Monocytes from VA-ECMO patients showed signs of dysfunction. Monocyte dysfunction, as determined by the unique tool F7, could be valuable for predicting mortality in patients receiving VA-ECMO and may be used as a novel biomarker guiding early clinical decision making in the future.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2021 Siegel, Orlean, Bojti, Kaier, Witsch, Esser, Trummer, Moser, Peter, Bode and Diehl.)
References: Br J Haematol. 2000 Nov;111(2):474-81. (PMID: 11122087)
Nat Rev Immunol. 2011 Oct 10;11(11):762-74. (PMID: 21984070)
Ann Rheum Dis. 1999 Apr;58(4):237-45. (PMID: 10364903)
Cardiovasc Res. 2015 Aug 1;107(3):321-30. (PMID: 25990461)
J Vis Exp. 2018 Oct 17;(140):. (PMID: 30394370)
Annu Rev Pharmacol Toxicol. 2015;55:489-511. (PMID: 25562645)
J Am Coll Cardiol. 2020 Aug 25;76(8):1001-1002. (PMID: 32819457)
Immunobiology. 2000 May;202(1):26-33. (PMID: 10879686)
Intensive Care Med. 2017 Sep;43(9):1306-1318. (PMID: 28470346)
Nat Immunol. 2016 Apr;17(4):406-13. (PMID: 26950237)
Cytometry B Clin Cytom. 2009 Mar;76(2):107-17. (PMID: 18727054)
Antioxid Redox Signal. 2013 Jun 10;18(17):2352-63. (PMID: 22900885)
J Immunol. 2008 May 1;180(9):6421-9. (PMID: 18424766)
J Cell Mol Med. 2020 Apr;24(8):4791-4803. (PMID: 32180339)
Virology. 2008 Jul 5;376(2):429-35. (PMID: 18452966)
Sci Rep. 2020 Jan 22;10(1):947. (PMID: 31969629)
Chest. 2008 Nov;134(5):1001-1008. (PMID: 18641108)
Immunol Cell Biol. 2014 Feb;92(2):133-8. (PMID: 24296810)
Crit Care. 2016 Nov 28;20(1):387. (PMID: 27890016)
Immunology. 1996 Dec;89(4):592-8. (PMID: 9014827)
Basic Res Cardiol. 2021 Mar 15;116(1):17. (PMID: 33721106)
Curr Opin Drug Discov Devel. 2007 Mar;10(2):153-9. (PMID: 17436550)
Clin Transl Med. 2015 Feb 14;4:5. (PMID: 25852821)
Crit Care. 2016 Oct 20;20(1):334. (PMID: 27760554)
Front Immunol. 2021 Jan 08;11:600684. (PMID: 33488595)
Intensive Care Med. 2000 Jul;26(7):883-92. (PMID: 10990102)
ASAIO J. 2019 Jan;65(1):77-83. (PMID: 29324513)
J Crit Care. 2017 Feb;37:130-135. (PMID: 27718412)
Crit Care. 2021 Jan 6;25(1):9. (PMID: 33407728)
Clin Chem. 2005 Dec;51(12):2341-7. (PMID: 16214828)
J Am Coll Cardiol. 1996 Nov 1;28(5):1127-33. (PMID: 8890805)
ASAIO J. 2017 Jan/Feb;63(1):60-67. (PMID: 27984321)
Ann Thorac Surg. 2021 May;111(5):1636-1642. (PMID: 32652073)
Immunol Rev. 2002 Aug;186:37-46. (PMID: 12234360)
Blood. 2007 Apr 15;109(8):3521-8. (PMID: 17164347)
Curr Opin Pediatr. 2016 Jun;28(3):267-73. (PMID: 27043087)
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):46. (PMID: 31346840)
فهرسة مساهمة: Keywords: DARPin®; Mac-1; activation; extracorporeal membrane oxygenation; inflammation; monocyte
تواريخ الأحداث: Date Created: 20210805 Latest Revision: 20210806
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8326337
DOI: 10.3389/fcvm.2021.689218
PMID: 34350217
قاعدة البيانات: MEDLINE
الوصف
تدمد:2297-055X
DOI:10.3389/fcvm.2021.689218